Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4546362 | 0.85 | P2RX3 (0.36) | P2RX3P2RX2 | |
| SCHEMBL29324345 | 0.79 | P2RX3 (0.34) | P2RX3P2RX2 | |
| SCHEMBL21041367 | 0.76 | P2RX3 (0.33) | P2RX3P2RX2 | |
| SCHEMBL23034513 | 0.74 | P2RX3 (0.36) | P2RX3P2RX2 | |
| SCHEMBL22697019 | 0.72 | — | — | |
| SCHEMBL21040589 | 0.72 | CYP17A1 (0.30) | — | |
| SCHEMBL22661740 | 0.71 | CYP17A1 (0.33) | — | |
| SCHEMBL2737342 | 0.71 | P2RX3 (0.33) | P2RX3P2RX2 | |
| SCHEMBL21347897 | 0.71 | MCOLN2 (0.36) | — | |
| SCHEMBL25484605 | 0.70 | CYP11B1 (0.33) | P2RX3P2RX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230331710-A1 | HETEROCYCLIC COMPOUND, PREPARATION METHOD AND USE THEREOF | SHANGHAI MEIYUE BIOTECH DEVELOPMENT CO. LTD (CN) | 2023-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230331710-A1 | HETEROCYCLIC COMPOUND, PREPARATION METHOD AND USE THEREOF | C9, CFB, C5 | P2RX3 1802/4885P2RX2 1261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.